Product NDC: | 33342-038 |
Proprietary Name: | Escitalopram Oxalate |
Non Proprietary Name: | Escitalopram Oxalate |
Active Ingredient(s): | 20 mg/21 & nbsp; Escitalopram Oxalate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 33342-038 |
Labeler Name: | Macleods Pharmaceuticals Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202210 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120911 |
Package NDC: | 33342-038-12 |
Package Description: | 100 TABLET, FILM COATED in 1 CARTON (33342-038-12) |
NDC Code | 33342-038-12 |
Proprietary Name | Escitalopram Oxalate |
Package Description | 100 TABLET, FILM COATED in 1 CARTON (33342-038-12) |
Product NDC | 33342-038 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Escitalopram Oxalate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20120911 |
Marketing Category Name | ANDA |
Labeler Name | Macleods Pharmaceuticals Limited |
Substance Name | ESCITALOPRAM OXALATE |
Strength Number | 20 |
Strength Unit | mg/21 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |